What is the most common side effect of prilocaine?
Which of the following is the preferred local anesthetic technique for hemophiliacs?
What effect does adrenaline have when used with local anesthetics?
A vial contains 4 ml of 2% lignocaine solution. How much lignocaine is present in 1 ml?
All of the following are surface anesthetics except:
What was the first local anesthetic agent used in clinical anesthesia?
What is true about EMLA cream?
Local anesthetics depress transmission first in which group of nerve fibers?
Local anesthetics act by:
Which of the following local anesthetics belongs to the ester group?
Explanation: **Explanation:** **Prilocaine** is an intermediate-acting amide local anesthetic. The correct answer is **Methemoglobinemia** because of its unique metabolic pathway. 1. **Why Methemoglobinemia is correct:** Prilocaine is metabolized in the liver and kidneys into **o-toluidine**. This metabolite is an oxidizing agent that converts hemoglobin (Fe²⁺) into methemoglobin (Fe³⁺). Methemoglobin cannot effectively bind or transport oxygen, leading to cyanosis and tissue hypoxia. This typically occurs when the dose exceeds 600 mg. 2. **Why other options are incorrect:** * **Respiratory arrest:** While local anesthetic systemic toxicity (LAST) can cause respiratory depression, it is a rare, life-threatening complication rather than the "most common" or specific side effect associated with prilocaine. * **Skin allergy:** Allergic reactions are more common with **ester-type** local anesthetics (due to PABA) than with amides like prilocaine. * **None:** Incorrect, as methemoglobinemia is a well-documented, classic side effect. **High-Yield Clinical Pearls for NEET-PG:** * **Treatment:** The drug of choice for prilocaine-induced methemoglobinemia is **Methylene Blue** (1–2 mg/kg IV over 5 minutes). * **EMLA Cream:** Prilocaine is a key component of EMLA (Eutectic Mixture of Local Anesthetics), which contains 2.5% Lidocaine and 2.5% Prilocaine. * **Contraindication:** Avoid prilocaine in patients with idiopathic methemoglobinemia, severe anemia, or those taking other oxidizing drugs (e.g., sulfonamides). * **Metabolism:** Unlike other amides, prilocaine is also metabolized in the **lungs and kidneys**, making its clearance faster than lidocaine.
Explanation: **Explanation:** The primary concern when administering anesthesia to patients with bleeding disorders like **hemophilia** is the risk of deep-tissue hemorrhage and the formation of life-threatening hematomas. **Why Intraligamentary (PDL) Injection is Preferred:** The **intraligamentary (periodontal ligament) injection** is the technique of choice because the anesthetic is delivered into the narrow space between the tooth root and the alveolar bone. This area is highly confined and lacks major blood vessels. Even if minor bleeding occurs, the dense connective tissue provides immediate **tamponade**, preventing the formation of a significant hematoma. It allows for localized pulpal anesthesia without the need for high-volume or deep-tissue penetration. **Analysis of Incorrect Options:** * **Nerve Block (e.g., IANB):** This is strictly **contraindicated** in hemophiliacs unless clotting factors are replaced. These blocks are administered into highly vascular, non-compressible spaces (like the pterygomandibular space). A needle prick here can cause a massive hematoma that may obstruct the airway. * **Supraperiosteal (Infiltration):** While safer than a nerve block, it involves injecting into loose connective tissue where bleeding is less contained than in the PDL space. * **Field Block:** Similar to nerve blocks, these involve larger volumes of anesthetic and deeper penetration into tissues where hemostasis cannot be easily controlled by local pressure. **High-Yield Clinical Pearls for NEET-PG:** * **Safe Techniques:** Intraligamentary, intrapulpal, and sometimes superficial buccal infiltrations are preferred. * **Factor Levels:** For minor dental procedures, factor levels should ideally be at **30-50%**. * **Avoid NSAIDs:** Post-operative pain in hemophiliacs should be managed with Acetaminophen; avoid Aspirin/NSAIDs due to platelet inhibition. * **Epinephrine:** The use of a vasoconstrictor in the LA solution is beneficial as it promotes local hemostasis.
Explanation: Adrenaline (Epinephrine) is the most common adjuvant added to local anesthetics (LA). Its primary mechanism is **vasoconstriction** via $\alpha_1$-adrenergic receptors, which leads to several clinical benefits: 1. **Reduced Systemic Absorption:** By constricting local blood vessels, adrenaline slows the rate at which the LA enters the systemic circulation. This keeps the drug concentrated at the nerve site and reduces the risk of **Systemic Toxicity (LAST)**. 2. **Prolonged Duration of Action:** Since the drug remains at the site of injection for a longer period due to decreased vascular washout, the duration of the nerve block is significantly extended (especially for short and intermediate-acting LAs like Lidocaine). 3. **Increased Maximum Permissible Dose:** Because systemic absorption is slower, the body can metabolize the drug more effectively as it trickles into the blood. This allows clinicians to safely administer a higher total dose of the LA (e.g., the max dose of Lidocaine increases from **3 mg/kg to 7 mg/kg** when adrenaline is added). **Why "All of the Above" is correct:** Options A, B, and C are all direct consequences of adrenaline-induced vasoconstriction. It allows for a higher safe dose (A), limits blood uptake (B), and keeps the block active longer (C). **High-Yield Clinical Pearls for NEET-PG:** * **Standard Concentration:** Adrenaline is typically used in a concentration of **1:200,000** (5 µg/mL). * **Contraindications:** Avoid using adrenaline in "end-artery" areas (fingers, toes, nose, penis, and pinna of the ear) due to the risk of **ischemic necrosis/gangrene**. * **Marker of Intravascular Injection:** Adrenaline acts as a "test dose" marker; an accidental intravascular injection will cause an immediate spike in heart rate and blood pressure.
Explanation: ### Explanation **1. Understanding the Concept (The "Rule of 10")** In pharmacology, the concentration of a solution expressed as a percentage (%) represents the number of grams of a drug in 100 ml of solution. * A **1% solution** means 1 gram in 100 ml. * 1 gram = 1000 mg. Therefore, 1000 mg / 100 ml = **10 mg/ml**. To find the concentration in mg/ml quickly, simply **multiply the percentage by 10**. For a **2% lignocaine solution**: $2 \times 10 = \mathbf{20\text{ mg/ml}}$. The total volume of the vial (4 ml) is a distractor in this specific question because the query asks for the amount in **1 ml**, not the total vial. **2. Analysis of Incorrect Options** * **Option A (2 mg):** This is a common error where the student forgets to convert grams to milligrams or fails to account for the "per 100 ml" definition. * **Option B (8 mg):** This is likely calculated by multiplying the percentage (2) by the volume (4), which is mathematically incorrect for determining concentration. * **Option D (200 mg):** This would be the concentration of a 20% solution, or the total amount of drug if the vial were 10 ml. **3. Clinical Pearls & High-Yield Facts for NEET-PG** * **Maximum Dose of Lignocaine:** * Plain Lignocaine: **3 mg/kg** * Lignocaine with Adrenaline (1:200,000): **7 mg/kg** * **Adrenaline Concentration:** 1:200,000 corresponds to **5 mcg/ml**. Adding adrenaline increases the duration of action and reduces systemic toxicity by causing vasoconstriction. * **Mechanism of Action:** Lignocaine blocks voltage-gated **sodium ($Na^+$) channels** in the inactivated state. * **Order of Nerve Block:** Pain > Temperature > Touch > Deep Pressure > Motor.
Explanation: **Explanation:** Surface (topical) anesthetics are local anesthetics (LAs) applied directly to mucous membranes (nose, mouth, throat, tracheobronchial tree, esophagus, and genitourinary tract) or damaged skin. To be effective topically, a drug must possess high lipid solubility and rapid penetrative power. **Why Bupivacaine is the Correct Answer:** **Bupivacaine** is a potent, long-acting amide local anesthetic primarily used for infiltration, nerve blocks, and spinal/epidural anesthesia. It has **poor mucosal penetration**, making it ineffective as a surface anesthetic. Clinically, its primary distinction is its high cardiotoxicity (due to slow dissociation from cardiac sodium channels). **Analysis of Other Options:** * **Lignocaine (Lidocaine):** The most versatile LA. It is highly effective topically and is available in various formulations (2% jelly, 4% solution, 10% spray) for procedures like catheterization or intubation. * **Cinchocaine (Dibucaine):** An amide LA that is highly potent and toxic. Due to its toxicity, its use is restricted almost exclusively to surface anesthesia (e.g., ointments for hemorrhoids). * **Procaine:** While traditionally known as the prototype ester LA for infiltration, it has very low topical activity. However, in the context of standard NEET-PG classifications, **Bupivacaine** is the more definitive "non-surface" agent because Procaine is occasionally used in specific topical formulations, whereas Bupivacaine is strictly injectable. *(Note: Some textbooks also classify Procaine as having poor surface activity; however, Bupivacaine’s lack of topical use is a classic exam distinction).* **High-Yield Clinical Pearls for NEET-PG:** * **Most Potent Surface Anesthetic:** Tetracaine (Amethocaine). * **Emla Cream:** A eutectic mixture of 2.5% Lignocaine and 2.5% Prilocaine used on intact skin. * **Cocaine:** The only naturally occurring LA and the only one with intrinsic vasoconstrictive properties; used in ENT surgeries. * **Benzocaine:** An ester LA used exclusively for surface anesthesia due to its low solubility; can cause methemoglobinemia.
Explanation: **Explanation:** **Cocaine** is the correct answer as it was the first local anesthetic used in clinical practice. It is a naturally occurring alkaloid derived from the leaves of the *Erythroxylon coca* plant. In **1884**, **Karl Koller**, an Austrian ophthalmologist, first demonstrated its clinical utility by using it for topical anesthesia during eye surgery. Shortly after, William Halsted used it to perform the first nerve block. **Analysis of Incorrect Options:** * **Procaine (Option D):** Synthesized by Alfred Einhorn in 1904, it was the first **synthetic** ester local anesthetic. It was developed to provide a less toxic alternative to cocaine. * **Lidocaine (Option C):** Synthesized by Nils Löfgren in 1943, it was the first **amide-linked** local anesthetic. It revolutionized the field due to its faster onset and greater stability compared to esters. * **Bupivacaine (Option A):** An amide anesthetic synthesized in 1957. It is known for its long duration of action and significant sensory-motor dissociation, but it was introduced much later than the others. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Local anesthetics work by blocking **voltage-gated sodium channels** on the inner surface of the nerve membrane. * **Unique Property:** Cocaine is the only local anesthetic that causes **vasoconstriction** (by inhibiting norepinephrine reuptake); all others are vasodilators (except ropivacaine/levobupivacaine which have mild vasoconstrictive effects). * **Metabolism:** **Esters** (Cocaine, Procaine) are metabolized by **pseudocholinesterase**, while **Amides** (Lidocaine, Bupivacaine) are metabolized in the **liver**. * **Rule of "i":** Amides have two "i"s in their name (L**i**doca**i**ne), while esters have only one (Coca**i**ne).
Explanation: **Explanation:** **EMLA (Eutectic Mixture of Local Anesthetics)** is a unique topical formulation consisting of a 1:1 ratio of **2.5% Lidocaine and 2.5% Prilocaine**. **Why Option B is correct:** The term "eutectic" refers to a mixture of two substances that, when combined in a specific ratio, results in a melting point lower than that of either individual component. While pure lidocaine and prilocaine are solids at room temperature, their mixture becomes an **oil/liquid**, allowing for a higher concentration of the drug to be absorbed through intact skin—a feat standard local anesthetics cannot achieve [1]. **Why other options are incorrect:** * **Option A:** EMLA is specifically designed for **intact skin** [1]. It is not used for intubation because it is not intended for mucosal surfaces (where absorption would be too rapid, risking toxicity) and takes too long to act for acute airway management. * **Option B:** Contrary to being "faster," EMLA has a **slow onset of action**. It requires a minimum application time of **45–60 minutes** under an occlusive dressing to achieve adequate dermal anesthesia. **High-Yield NEET-PG Pearls:** 1. **Clinical Use:** Primarily used for painless venipuncture, skin graft harvesting, and minor superficial surgeries. 2. **Depth of Anesthesia:** It penetrates to a depth of approximately **3–5 mm**. 3. **Contraindication:** It should not be used in infants under 1 month or those with **methemoglobinemia**, as Prilocaine (via its metabolite o-toluidine) can exacerbate the condition. 4. **Side Effects:** Localized blanching or erythema at the application site.
Explanation: **Explanation:** The sensitivity of nerve fibers to local anesthetics (LAs) is determined by fiber diameter, myelination, and the length of the nerve exposed to the drug. **Why Group C fibers are the correct answer:** According to the **Gasser-Erlanger classification**, sensitivity to local anesthetics generally follows the rule: **Small > Large** and **Myelinated > Unmyelinated**. However, in clinical practice, the **B-fibers** (preganglionic autonomic) are actually the most sensitive because they are small and myelinated. Among the options provided, **Group C fibers** (small, unmyelinated) are blocked before **Group A fibers** (large, myelinated). Group C fibers carry slow pain and temperature sensations; their small diameter allows the LA to reach the sodium channels more rapidly despite the lack of myelin. **Analysis of Incorrect Options:** * **Group A alpha-fibers (Aα):** These are the largest, most heavily myelinated fibers responsible for motor function and proprioception. They are the **most resistant** to LA block. * **Group A beta-fibers (Aβ):** These are large fibers responsible for touch and pressure. Like Aα, they have a large diameter, making them less sensitive than C fibers. * **Group B fibers:** While B-fibers are technically the *first* to be blocked in a clinical setting (autonomic block), if the question specifically focuses on the sequence leading to sensory loss or if B-fibers are not considered the "primary" sensory target in the context of the question's source, C-fibers are the standard answer for the first sensory modality lost. **NEET-PG High-Yield Pearls:** 1. **Sequence of Blockade:** Autonomic (B) → Pain/Temperature (C & Aδ) → Touch/Pressure (Aβ) → Motor (Aα). 2. **Critical Length:** At least **3 nodes of Ranvier** must be submerged in LA to interrupt conduction in myelinated fibers. 3. **Recovery Sequence:** The recovery occurs in the exact **reverse order** of the block (Motor recovers first, Autonomic last). 4. **pH Effect:** LAs are weak bases. In acidic environments (e.g., infected tissue), they become ionized and cannot cross the lipid membrane, leading to decreased efficacy.
Explanation: **Mechanism of Action: Local Anesthetics** **Explanation of the Correct Answer:** Local anesthetics (LAs) are membrane-stabilizing drugs that primarily act by blocking **voltage-gated sodium (Na+) channels**. The LA molecule exists in an equilibrium between an uncharged (lipid-soluble) base and a charged (water-soluble) cation. The uncharged base diffuses across the axonal phospholipid bilayer. Once inside the axoplasm, it re-ionizes into the charged form. This charged cation then binds to a specific receptor site located on the **inner (cytoplasmic) gate** of the sodium channel. This binding stabilizes the channel in an inactive state, preventing sodium influx, which inhibits depolarization and the propagation of action potentials. **Analysis of Incorrect Options:** * **Option B:** The outer gate (activation gate) is not the primary binding site for LAs. While some toxins (like Tetrodotoxin) block the outer pore, clinical LAs must access the internal side of the membrane to be effective. * **Options C & D:** While high concentrations of LAs may have minor effects on potassium (K+) or calcium channels, their primary clinical mechanism for anesthesia and analgesia is strictly the inhibition of sodium channels. Potassium channels are responsible for repolarization, not the initiation of the action potential. **High-Yield Clinical Pearls for NEET-PG:** * **State-Dependent Block:** LAs have a higher affinity for channels in the **activated (open)** or **inactivated** states rather than the resting state. This is why "frequently firing" nerves are blocked faster (Use-dependent block). * **Order of Blockade:** Small, myelinated fibers (B and A-delta) are blocked before large, unmyelinated fibers. Clinically, the sequence is: **Autonomic > Pain > Temperature > Touch > Pressure > Motor.** * **Effect of pH:** LAs are weak bases. In acidic environments (e.g., infected/inflamed tissue), more drug remains in the ionized form outside the cell, preventing it from crossing the membrane, which leads to **reduced efficacy**.
Explanation: Local anesthetics are clinically classified into two categories based on the chemical linkage between their aromatic and hydrophilic ends: **Esters** and **Amides**. ### **Explanation of the Correct Answer** **A. Procaine** is the correct answer because it contains an ester linkage. Ester-linked local anesthetics are metabolized by **plasma pseudocholinesterase**. A high-yield mnemonic to identify them is that their names contain only **one "i"** (e.g., Procaine, Chloroprocaine, Benzocaine, Tetracaine, Cocaine). ### **Analysis of Incorrect Options** Options B, C, and D are all **Amide-linked** local anesthetics. Amides are metabolized primarily in the **liver** by microsomal enzymes (CYP450). A simple rule for identification is that amide names contain **two "i"s** (one in the prefix and one in the "-caine" suffix): * **B. Bupivacaine:** A long-acting amide; notable for its cardiotoxicity. * **C. Lignocaine (Lidocaine):** The most commonly used amide; also used as a Class Ib antiarrhythmic. * **D. Mepivacaine:** An amide with intermediate duration; notably lacks vasodilator properties. ### **Clinical Pearls for NEET-PG** * **Allergy:** Esters are more likely to cause allergic reactions due to their metabolite, **Para-aminobenzoic acid (PABA)**. Amide allergies are extremely rare. * **Cocaine Exception:** Cocaine is the only ester that is a potent vasoconstrictor (others are vasodilators) and the only one metabolized significantly by the liver. * **Prilocaine:** An amide associated with **methemoglobinemia** (treated with Methylene blue). * **Bupivacaine:** Most cardiotoxic; **Levobupivacaine** and **Ropivacaine** are safer S-enantiomer alternatives.
Chemistry and Mechanism of Action
Practice Questions
Pharmacokinetics of Local Anesthetics
Practice Questions
Amide Local Anesthetics
Practice Questions
Ester Local Anesthetics
Practice Questions
Clinical Uses of Local Anesthetics
Practice Questions
Toxicity of Local Anesthetics
Practice Questions
Management of Local Anesthetic Systemic Toxicity
Practice Questions
Adjuvants to Local Anesthetics
Practice Questions
Maximum Safe Doses
Practice Questions
Local Anesthetics in Special Populations
Practice Questions
Allergic Reactions to Local Anesthetics
Practice Questions
Future Developments in Local Anesthetics
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free